Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Cladribine EP Impurity A, 4546-70-7
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
Yes -Refer MSDS for accurate information
Cladribine EP Impurity A is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Cladribine EP Impurity A usage and description
Cladribine, also known as 2-chlorodeoxyadenosine, is a chemotherapy drug used in the treatment of certain types of cancer, including hairy cell leukemia and multiple sclerosis. Cladribine EP Impurity A is a chemical impurity that can be found in small quantities in Cladribine.
The chemical formula of Cladribine EP Impurity A is C10H12ClN5O3, which indicates that it contains carbon, hydrogen, nitrogen, oxygen, and chlorine atoms. This impurity has a molecular weight of 287.7 g/mol and a melting point of approximately 229-231°C.
Although Cladribine EP Impurity A is not the main active ingredient in Cladribine, it is important to monitor its presence and concentration as it can affect the efficacy and safety of the drug. The impurity can be formed during the synthesis of Cladribine or during storage and handling of the drug.
To ensure the purity and quality of Cladribine, pharmaceutical manufacturers must adhere to strict guidelines and regulations set forth by regulatory agencies such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These guidelines require the testing and monitoring of impurities such as Cladribine EP Impurity A to ensure that the drug is safe and effective for use in patients.
